Cargando…

Spatially-resolved quantification of proteins in triple negative breast cancers reveals differences in the immune microenvironment associated with prognosis

Triple negative breast cancer (TNBC) is an aggressive breast cancer subtype. Recent studies have shown that MHC class II (MHCII) expression and tumor infiltrating lymphocytes are important prognostic factors in patients with TNBC, although the relative importance of lymphocyte subsets and associated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stewart, Rachel L., Matynia, Anna P., Factor, Rachel E., Varley, Katherine E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170957/ https://www.ncbi.nlm.nih.gov/pubmed/32313087 http://dx.doi.org/10.1038/s41598-020-63539-x

Ejemplares similares

Spatially resolved transcriptomics reveals the architecture of the tumor-microenvironment interface
por: Hunter, Miranda V., et al.
Publicado: (2021)

Approaches to spatially resolving the tumour immune microenvironment of hepatocellular carcinoma
por: Marsh-Wakefield, Felix, et al.
Publicado: (2022)

Immune checkpoints expression patterns in early-stage triple-negative breast cancer predict prognosis and remodel the tumor immune microenvironment
por: Zhang, Jinguo, et al.
Publicado: (2023)

Spatially resolved immune exhaustion within the alloreactive microenvironment predicts liver transplant rejection
por: Barbetta, Arianna, et al.
Publicado: (2023)

Multiplexed imaging analysis of the tumor-immune microenvironment reveals predictors of outcome in triple-negative breast cancer
por: Patwa, Aalok, et al.
Publicado: (2021)

Identification of Key Genes Affecting the Tumor Microenvironment and Prognosis of Triple-Negative Breast Cancer
por: Yi, Jiarong, et al.
Publicado: (2021)

XYZeq: Spatially resolved single-cell RNA sequencing reveals expression heterogeneity in the tumor microenvironment
por: Lee, Youjin, et al.
Publicado: (2021)

Characterization of Exosome-Related Gene Risk Model to Evaluate the Tumor Immune Microenvironment and Predict Prognosis in Triple-Negative Breast Cancer
por: Qiu, Pengjun, et al.
Publicado: (2021)

A risk scoring system based on tumor microenvironment cells to predict prognosis and immune activity in triple-negative breast cancer
por: Yang, Anli, et al.
Publicado: (2022)

How many diseases is triple negative breast cancer: the protagonism of the immune microenvironment
por: Saraiva, Diana P, et al.
Publicado: (2017)

Integrating Genomic Information with Tumor-Immune Microenvironment in Triple-Negative Breast Cancer
por: Otohinoyi, David, et al.
Publicado: (2022)

Integrated multiomic data analysis reveals the clinical significance of TXNIP and contributing to immune microenvironment in triple negative breast cancer
por: Gong, Han, et al.
Publicado: (2023)

Resolving the spatial architecture of myeloma and its microenvironment at the single-cell level
por: John, Lukas, et al.
Publicado: (2023)

Spatial Profile of Tumor Microenvironment in PD-L1-Negative and PD-L1-Positive Triple-Negative Breast Cancer
por: Tashireva, Liubov A., et al.
Publicado: (2023)

A novel model associated with tumor microenvironment on predicting prognosis and immunotherapy in triple negative breast cancer
por: Zhang, Juan, et al.
Publicado: (2023)

Enhanced Thermogenesis in Triple-Negative Breast Cancer Is Associated with Pro-Tumor Immune Microenvironment
por: Gandhi, Shipra, et al.
Publicado: (2021)

Classification of triple negative breast cancer by epithelial mesenchymal transition and the tumor immune microenvironment
por: Font-Clos, Francesc, et al.
Publicado: (2022)

The Characteristics of Tumor Microenvironment in Triple Negative Breast Cancer
por: Fan, Yiqi, et al.
Publicado: (2022)

Crosstalk between triple negative breast cancer and microenvironment
por: Smrekar, Karly, et al.
Publicado: (2023)

Distinct spatial immune microlandscapes are independently associated with outcomes in triple-negative breast cancer
por: Carter, Jodi M., et al.
Publicado: (2023)

An activity-dependent proximity ligation platform for spatially resolved quantification of active enzymes in single cells
por: Li, Gang, et al.
Publicado: (2017)

Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer
por: Qiu, Jingdan, et al.
Publicado: (2016)

Epigenetic quantification of circulating immune cells in peripheral blood of triple-negative breast cancer patients
por: Manoochehri, Mehdi, et al.
Publicado: (2021)

Adipogenesis in triple-negative breast cancer is associated with unfavorable tumor immune microenvironment and with worse survival
por: Oshi, Masanori, et al.
Publicado: (2021)

Ethnic disparities in the immune microenvironment of triple negative breast cancer and its role in therapeutic outcomes
por: Zajac, Kelsee K., et al.
Publicado: (2023)

Regulatory T cells are associated with the tumor immune microenvironment and immunotherapy response in triple-negative breast cancer
por: Huang, Pengfei, et al.
Publicado: (2023)

Role of ICAM1 in tumor immunity and prognosis of triple-negative breast cancer
por: Zhou, Qin, et al.
Publicado: (2023)

Pan-cancer spatially resolved single-cell analysis reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment
por: Ma, Chenxi, et al.
Publicado: (2023)

Comparison of the tumor immune microenvironment of primary hormone receptor-negative HER2-positive and triple negative breast cancer
por: Vos, Hanne, et al.
Publicado: (2021)

Assay‐agnostic spatial profiling detects tumor microenvironment signatures: new diagnostic insights for triple‐negative breast cancer
por: Ziegler, Colleen, et al.
Publicado: (2023)

Quantification of HER1, HER2 and HER3 by time-resolved Förster resonance energy transfer in FFPE triple-negative breast cancer samples
por: Ho-Pun-Cheung, Alexandre, et al.
Publicado: (2019)

Stable Isotope-Resolved Metabolomic Differences between Hormone-Responsive and Triple-Negative Breast Cancer Cell Lines
por: Winnike, Jason H., et al.
Publicado: (2018)

Triple negative breast cancer: Immunogenicity, tumor microenvironment, and immunotherapy
por: Loizides, Sotiris, et al.
Publicado: (2023)

Addendum: Crosstalk between triple negative breast cancer and microenvironment
por: Smrekar, Karly, et al.
Publicado: (2023)

Spatial maps of hepatocellular carcinoma transcriptomes reveal spatial expression patterns in tumor immune microenvironment
por: Wang, Yue-fan, et al.
Publicado: (2022)

Technique integration of single-cell RNA sequencing with spatially resolved transcriptomics in the tumor microenvironment
por: Yan, Hailan, et al.
Publicado: (2022)

Immune microenvironment changes induced by neoadjuvant chemotherapy in triple-negative breast cancers: the MIMOSA-1 study
por: Sarradin, Victor, et al.
Publicado: (2021)

An Immune-Related Gene Prognostic Index for Triple-Negative Breast Cancer Integrates Multiple Aspects of Tumor-Immune Microenvironment
por: Wang, Xiaowei, et al.
Publicado: (2021)

Identification of immune-related signature for the prognosis and benefit of immunotherapy in triple-negative breast cancer
por: Sun, Xiaorui, et al.
Publicado: (2022)

Spatially resolved analyses link genomic and immune diversity and reveal unfavorable neutrophil activation in melanoma
por: Mitra, Akash, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ept711flginoo7g091cinuvcf2